| FRA7G |
|
fragile site, aphidicolin type, common, fra(7)(q31.2)
|
|
|
0.695 |
0.462 |
| GCY |
|
growth control, Y chromosome influenced
|
|
|
0.631 |
0.615 |
| HOXA@ |
|
homeobox A cluster
|
|
|
0.599 |
0.654 |
| HOXB@ |
|
homeobox B cluster
|
|
|
0.631 |
0.538 |
| HOXD@ |
|
homeobox D cluster
|
|
|
0.631 |
0.538 |
| HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| RMRP |
|
RNA component of mitochondrial RNA processing endoribonuclease
|
|
|
0.519 |
0.731 |
| SAI1 |
|
suppression of anchorage independence 1
|
|
|
0.560 |
0.615 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| TERC |
|
telomerase RNA component
|
|
|
0.471 |
0.846 |
| UGT1A |
|
UDP glucuronosyltransferase family 1 member A complex locus
|
|
|
0.540 |
0.654 |
| XIST |
|
X inactive specific transcript
|
|
|
0.522 |
0.808 |
| LAP |
|
Laryngeal adductor paralysis
|
|
|
0.619 |
0.731 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| RNU1-1 |
|
RNA, U1 small nuclear 1
|
|
|
0.608 |
0.731 |
| MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
| ERVK-6 |
|
endogenous retrovirus group K member 6, envelope
|
|
|
0.521 |
0.808 |
| MIR155HG |
|
MIR155 host gene
|
|
|
0.617 |
0.615 |
| PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
| NEAT1 |
|
nuclear paraspeckle assembly transcript 1
|
|
|
0.502 |
0.769 |
| PWAR4 |
|
Prader Willi/Angelman region RNA 4
|
|
|
0.573 |
0.769 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |